Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
12/09/2025
Market research firm Rho Motion stated on Friday that global sales of battery electric vehicles and plug-in hybrid electric vehicles in August grew by 15% year-on-year, marking the slowest growth rate since January.
Latest
1 m ago
After a sharp decline yesterday, today Hong Kong stocks in the innovative pharmaceutical concept sector rebounded across the board. As of the time of publication, Konruns Pharmaceuticals-B rose more than 14%, Huang Pharmaceutical rose more than 6%, Rundong Pharmaceuticals, Liputan Biological-B rose more than 5%, and Geco-B rose more than 4%. On the news front, many pharmaceutical companies responded, stating that they are aware of market rumors that the United States may limit innovative drugs from China, but believe that these rumors currently do not affect the expectations for Chinese innovative drugs to go global. Market participants believe that leading biotech companies such as BeiJing ShenZhou and Xinda Pharmaceuticals are expected to maintain a high growth trend after achieving a profit turning point in 2025. With the improvement of industrialization capabilities and expansion of product lines, it is expected that more biotech companies will enter the profit cycle in the future. (First Financial News)
1 m ago
Legence, supported by Blackstone Group, raised $728 million in its initial public offering.
1 m ago
Legence, supported by Blackstone Group, raised 728 million dollars in its initial public offering (IPO).
3 m ago
The General Administration of Market Supervision unconditionally approves KKR's acquisition of shares in Sibaggi Company.
3 m ago
Hangzhou Shangcheng District Artificial Intelligence Industry Development Company was established and registered with a capital of 100 million RMB.
See all latest